Remove DEA Remove Dispensary Remove Hemp Remove Legalization
article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

The federally sanctioned cannabis did not reflect the products available in dispensaries around the country, researchers complain, limiting the scope of research and pushing much of it overseas. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. Shutterstock).

DEA 133
article thumbnail

CBD and Hemp Legal and Regulatory Roundup – May 13, 2022

Cannabis Law Report

Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news: CBD. hemp grower, CBD producer moves into high THC space. With the success of its hemp products and the passage of Vt.’s With the success of its hemp products and the passage of Vt.’s Brattleboro Reformer. Law 360 (sub. Law 360 (sub.

Hemp 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

U.S. Cannabis Legalization Update: Who’s Still Waiting and Who May Legalize

Veriheal

states and the District of Columbia currently have legal cannabis, medical or recreational. Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. To its credit, the state does seem to be making minor strides toward cannabis legalization lately.

article thumbnail

The DEA Is Finally About to End the Federal Monopoly on Research Cannabis Cultivators

SpeedWeed

After years of delays, legal challenges, and obfuscation, the US Drug Enforcement Agency (DEA) finally announced that it would begin evaluating applications for federally-licensed research cannabis cultivators. . In 2019, a federal judge forced the DEA to explain its inaction.

DEA 52
article thumbnail

Study Finds Research-Grade Cannabis Differs From Commercial Cannabis

Veriheal

According to a new study published in September, the cannabis grown by the federal government for research purposes doesn’t accurately reflect what consumers are buying in dispensaries across the United States. The findings have raised serious questions about the efficacy of federal cannabis research. or less THC. .” ” U.S.

DEA 104
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

Though it doesn’t get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 51
article thumbnail

The Week in Weed: April 3, 2020

The Blunt Truth

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. We’ve talked quite a bit about South Dakota over the years; most recently, we’ve been watching the progress of their hemp legalization legislation. DEA GUIDANCE. LEGALIZATION EFFORTS.

DEA 101